When will Compass Pathways submit a NDA for COMP360 psilocybin? (COMP360 psilocybin - NDA)
98%before December
- before December98%▲ 6
- before 202798%▲ 5
- before April 202798%
Install
Will the FDA approve a cure for Type 1 diabetes before 2033?
The odds
38%chance
How the odds have moved
Yes: 39% on Oct 20, 38% now.
Each outcome's chance over time on Kalshi. The dots along the bottom are headlines about its subject: point at one to read it.
Every outcome
| Outcome | Chance | Day | Bid | Ask | Pays | Contracts |
|---|---|---|---|---|---|---|
| Yes | 38% | 35¢ | 41¢ | $2.44 | 10.8K |
"Pays" is what a $1 stake returns if that outcome happens, at the price shown (before any fees). Bid and ask are the best prices to sell and buy "Yes".
The news: FDA, Type
Search ›- FDA grants tentative approval to low-cost HIV shotThe potential rollout of a more affordable injection to help prevent HIV infection lifts hopes for reduced AIDS deaths in Africa. US regulatorsâ approval of a cheaper HIV shot has lifted hopes in some of the worldâs poorest countries…
- The best makeup remover for every type of makeupRemoving makeup at the end of a long day or night out is one of my least favorite parts of my routine, and I’ll admit that it’s a step I sometimes skip. To make matters worse, when I do remove it, I’ll sometimes see leftover foundation on…
- Bacterial or viral? FDA clears rapid test distinguishing type of infectionThe FDA granted clearance to a rapid blood test designed to distinguish between bacterial and viral infections in as little as 15 minutes, according to the test’s manufacturer. The test — known as Access MeMed BV (MeMed) — has been cleared…
- Pharma critic Bernie Sanders is set to hold major sway over FDA funding billSTAT WASHINGTON – Democrats’ landslide victory in the midterm elections may have significant implications for the upcoming negotiations over a key funding source for the Food and Drug Administration in part by empowering a major critic of…
- FDA, CMS look to collaborate with states on health AISTAT is a media company focused on finding and telling compelling stories about health, medicine, and scientific discovery. We produce daily news, investigative articles, and narrative projects in addition to multimedia features, podcasts…
- Type 1 vs. Type 2 DiabetesDiabetes is a condition that impacts how your body uses food and turns it into energy. Diabetes is a condition that impacts how your body uses food and turns it into energy.When you eat, your body breaks down your food into a type of sugar…
- The CCCH-type zinc-finger PfMD3 promotes translation for malaria parasite transmissionSince PfMD3 is necessary to produce fertile male gametocytes, we used RNA-sequencing to measure changes in mRNA abundance between ΔPfMD31.1 and NF54e gametocytes at Stage II and V of development (5 and 11 days post gametocyte induction…
- Pharmalittle: We’re reading about CVS plans to split up, FDA inspections in India and China and moreEd Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for more than three decades. His stories explore prescription drug pricing, affordability and access, as well issues surrounding…
- Inovio’s DNA-Based Immunotherapy Lands Speedy FDA Nod for Rare Type of TumorInovio’s Voceryq will compete with a Precigen product that last year became the first FDA-approved drug for recurrent respiratory papillomatosis, or RRP. While the two immunotherapies carry the same $460,000 list price, Inovio executives…
- Type 1 Hypervisor vs. Type 2: What’s the Difference?Chris Hayhurst is a contributor to the CDW family of technology magazines. One firm wants to allow its employees to access their files and applications from anywhere. The IT team at a second company is focused on its disaster recovery…
- Four types of House races to watch on election night to know how it might goPeople cast their ballots on the first day of early voting for the midterm elections, in New York, on Oct. 24, 2026. Ryan Murphy/AFP via Getty Images hide caption Midterms coverage: Live results | What to know | Stories around the…
- Automated insulin delivery raises time in range in type 1, type 2 diabetesMost people with type 1 or type 2 diabetes achieved target continuous glucose monitoring metrics while using the twiist automated insulin delivery system, according to real-world data. “The message is simple and clear — automated insulin…
Related markets
All fda & drugs ›Will the FDA approve retatrutide? (retatrutide (LY3437943))
Dec 9, 2027even chance by
- Before Jan 1, 20272%
- Before Jul 1, 202712%▼ 9
- Before Jan 1, 202856%
2 more
- Before Jul 1, 202885%
- Before Jan 1, 202990%
Will the FDA approve any psychedelic substance for medical use this year? (Before 2027)
16%chance▼ 1
When will the FDA reclassify BPC-157 to Category 1?
10%Before 2027
- Before 202710%▲ 1
When will the FDA approve Compass Pathways' COMP360 Psilocybin? (COMP360 Psilocybin for Treatment-Resistant Depression)
90%Before 2028
- Before 202890%▼ 1
- Before October 202788%▼ 1
- Before July 202787%
2 more
- Before Mar 1, 202765%▼ 1
- Before Jan 1, 202719%▲ 2
FDA decision: Saroglitazar by Zydus Therapeutics (in 2026)
74%chance▼ 1
Odds are traders' prices on Kalshi, Polymarket, ForecastEx and Crypto.com, not forecasts by 4Progressives. Prices read from the venues just now. Prices may be delayed. Money traded on Kalshi and ForecastEx is estimated from contracts. Not betting or investment advice.
Prediction-market prices are what traders pay for each outcome on Kalshi, Polymarket, ForecastEx and Crypto.com, read as the market's implied chance. They are not forecasts by 4Progressives, can move fast and can be wrong; they are read every few minutes and may be delayed. Money traded on Kalshi and ForecastEx is estimated from contracts at their price. News comes from the 4Progressives index; prices of stocks, rates and coins from 4Progressives Finance. Nothing here is betting, financial or investment advice. Terms of use. How to use Predictions